0001209191-18-015306.txt : 20180301
0001209191-18-015306.hdr.sgml : 20180301
20180301205013
ACCESSION NUMBER: 0001209191-18-015306
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180228
FILED AS OF DATE: 20180301
DATE AS OF CHANGE: 20180301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Aspauza Jossie
CENTRAL INDEX KEY: 0001624298
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32381
FILM NUMBER: 18659778
MAIL ADDRESS:
STREET 1: 800 W. OLYMPIC BLVD
STREET 2: SUITE 406
CITY: LOS ANGELES
STATE: CA
ZIP: 90015
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HERBALIFE LTD.
CENTRAL INDEX KEY: 0001180262
STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: P.O. BOX 309GT
STREET 2: UGLAND HOUSE, SOUTH CHURCH STREET
CITY: GEORGE TOWN
STATE: E9
ZIP: 00000
BUSINESS PHONE: 310 410 9600
MAIL ADDRESS:
STREET 1: P.O. BOX 309GT
STREET 2: UGLAND HOUSE, SOUTH CHURCH STREET
CITY: GEORGE TOWN
STATE: E9
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: WH HOLDINGS CAYMAN ISLANDS LTD
DATE OF NAME CHANGE: 20020814
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-02-28
0
0001180262
HERBALIFE LTD.
HLF
0001624298
Aspauza Jossie
800 W. OYMPIC BLVD.
SUITE 406
LOS ANGELES
CA
90015
0
1
0
0
VP, SAM/CAM
Common Stock
2018-02-28
4
M
0
2512
79.58
A
14592
D
Common Stock
2018-02-28
4
D
0
2171
92.10
D
12421
D
Common Stock
2018-02-28
4
F
0
103
92.10
D
12318
D
Common Stock
2018-02-28
4
M
0
3752
59.98
A
16070
D
Common Stock
2018-02-28
4
D
0
2444
92.10
D
13626
D
Common Stock
2018-02-28
4
F
0
393
92.10
D
13233
D
Common Stock
2018-02-28
4
M
0
1048
62.51
A
14281
D
Common Stock
2018-02-28
4
D
0
712
92.10
D
13569
D
Common Stock
2018-02-28
4
F
0
102
92.10
D
13467
D
Common Stock
2018-02-28
4
M
0
1102
57.19
A
14569
D
Common Stock
2018-02-28
4
D
0
685
92.10
D
13884
D
Common Stock
2018-02-28
4
F
0
126
92.10
D
13758
D
Common Stock
2018-02-28
4
S
0
9995
90.38
D
3763
D
Stock Appreciation Rights
79.58
2018-02-28
4
M
0
2512
0.00
D
2016-06-21
2023-12-19
Common Stock
2512
0
D
Stock Appreciation Rights
59.98
2018-02-28
4
M
0
3752
0.00
D
2017-04-30
2024-04-30
Common Stock
3752
0
D
Stock Appreciation Rights
62.51
2018-02-28
4
M
0
1048
0.00
D
2017-05-09
2026-05-09
Common Stock
1048
4192
D
Stock Appreciation Rights
57.19
2018-02-28
4
M
0
1102
0.00
D
2018-02-27
2027-02-27
Common Stock
1102
4406
D
The reporting person received 238 shares of common stock upon the net exercise of 2,512 stock appreciation rights ("SARs"). The reporting person forfeited 2,171 shares of common stock underlying the SARs in payment of the exercise price and 103 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 28, 2018 of $92.10.
The reporting person received 915 shares of common stock upon the net exercise of 3,752 SARs. The reporting person forfeited 2,444 shares of common stock underlying the SARs in payment of the exercise price and 393 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 28, 2018 of $92.10.
The reporting person received 234 shares of common stock upon the net exercise of 1,048 SARs. The reporting person forfeited 712 shares of common stock underlying the SARs in payment of the exercise price and 102 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 28, 2018 of $92.10.
The reporting person received 291 shares of common stock upon the net exercise of 1,102 SARs The reporting person forfeited 685 shares of common stock underlying the SARs in payment of the exercise price and 126 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 28, 2018 of $92.10.
This transaction was executed in multiple trades at prices ranging from $90.11 to $90.65. The price reported reflects the weighted average sale price of $90.38. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Consists of stock appreciation rights granted under the Herbalife Ltd. 2014 Stock Incentive Plan, of which 20% vested May 9, 2017, and 20% will vest on May 9, 2018, and the remaining 60% will vest May 9, 2019.
Consists of stock appreciation rights granted under the Herbalife Ltd. 2014 Stock Incentive Plan, of which 20% vested February 27, 2018, 20% will vest February 27, 2019, and the remaining 60% will vest February 27, 2020.
/s/ Eileen Uy, Attorney-in-Fact for Jossie Aspauza
2018-03-01